v3.25.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue:    
Total revenue $ 211,789 $ 67,453
Operating costs and expenses:    
Payroll 34,860 27,003
Contract services 38,655 11,319
Medical supplies 3,801 5,322
Depreciation and amortization 5,092 4,186
Other 11,043 9,466
Total operating costs and expenses 93,451 57,296
Gross profit 118,338 10,157
Corporate and other costs:    
Stock-based compensation 36,094 49
General and administrative expenses 10,035 8,658
Total corporate and other costs 46,129 8,707
Operating income (loss) 72,209 1,450
Interest expense, net 6,120 4,444
Loss on warrant liability   (2,601)
Other expense (income) 3,325 (241)
Income (loss) before taxes 62,764 (152)
Income tax expense (benefit) 18,541 390
Net income (loss) 44,223 (542)
Less: net income (loss) attributable to noncontrolling interests 29,589 (178)
Net income (loss) attributable to Nutex Health Inc. $ 14,634 $ (364)
Earnings (loss) per common share    
Basic, Earnings (loss) per common share (in dollars per share) $ 2.65 $ (0.08)
Diluted, Earnings (loss) per common share (in dollars per share) $ 2.56 $ (0.08)
Hospital division    
Revenue:    
Total revenue $ 203,947 $ 60,029
Population health management division    
Revenue:    
Total revenue $ 7,842 $ 7,424